Home › Cardiovascular Disease › NCT07478354
Heart Institute BioRepository (HIBR) for Pediatric Heart Disease
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria * Any fetus, child or adult at risk of or diagnosed with Pediatric Heart Disease (PHD) or Cardiovascular Disease (CVD) * Any HI patient, including the following types of encounters: Surgery or Cardiac Catheterization or Advanced Imaging encounters, Inpatient, including Cardiology service, consultation patients and Fetal Delivery, and Outpatient, including all HI-associated clinics and consultation services * Any female carrying a fetus with a suspected cardiac diagnosis Exclusion Criteria * Legal guardian unauthorized to consent * Families who choose Palliative care during pregnancy
About the study
The purpose of this protocol is to redefine the Heart Institute BioRepository (HIBR) to facilitate Investigator-initiated and programmatic basic, translational, clinical and outcomes research. For the purposes of this protocol, "tissue" will refer to any gross specimen obtained from a patient, including but not limited to blood, cardiovascular tissue, urine, saliva, and other tissues and bodily fluids, including explanted non-human prosthetics or grafts. In this context, "tissue" is synonymous with "sample" or "specimen." A "BioRepository" functions to systematically collect, maintain and govern tissue specimens.
Sponsor: Children's Hospital Medical Center, Cincinnati · Participants: 5,000 · Started: Jan 27, 2012
Contact the study team
- Jeffrey Alten, MD · Phone: 513-636-2871
Official record on ClinicalTrials.gov — NCT07478354
Locations in the U.S.
| Ohio | Children's Hospital Medical Center, Cincinnati, Cincinnati |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.